Publications by authors named "Ryan Pelletier"

Claim this Profile
U
Unpacking Oral Challenge Protocols: A Descriptive Epidemiologic Study of Reactions, Predictors, and Practices for Delabeling Low-Risk Penicillin Allergies Leveraging Data from a Systematic Review and Meta-Analysis.
Mira Maximos, Ryan Pelletier, Sameer Elsayed, Colleen J Maxwell, Sherilyn K D Houle

Hosp Pharm· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review and meta-analysis of interventions to delabel low-risk penicillin allergies with consideration for sex and gender.
Mira Maximos, Ryan Pelletier, Sameer Elsayed, Colleen J Maxwell, Sherilyn K D Houle

Br J Clin Pharmacol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocol for a systematic review and meta-analysis of interventions aimed at delabeling low-risk penicillin allergies with consideration for sex and gender.
Mira Maximos, Sameer Elsayed, Colleen Maxwell, Sherilyn K D Houle, Ryan Pelletier

Syst Rev· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in bleeding risk estimates among online calculators: Cross-sectional study of apps used by and for patients with atrial fibrillation.
Ryan Pelletier, Jeff Nagge, John-Michael Gamble

Can Fam Physician· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Drug Interaction of the Sodium Glucose Co-Transporter 2 Inhibitors with Statins and Myopathy: A Disproportionality Analysis Using Adverse Events Reporting Data.
Wajd Alkabbani, Ryan Pelletier, Michael A Beazely, Youssef Labib, Breanna Quan

Drug Saf· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events.
Wajd Alkabbani, Ryan Pelletier, John-Michael Gamble

Am J Epidemiol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the risk of venous thromboembolism (VTE) in ambulatory patients with cancer: Rationale and implementation of a pharmacist-led VTE risk assessment program in an ambulatory cancer centre.
Ryan Pelletier

J Oncol Pharm Pract· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events associated with sodium glucose co-transporter 2 inhibitors: an overview of quantitative systematic reviews.
Ryan Pelletier, Kelvin Ng, Wajd Alkabbani, Youssef Labib, Nicolas Mourad

Ther Adv Drug Saf· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of sodium-glucose cotransporter 2 inhibitors with cancer: An overview of quantitative systematic reviews.
Ryan Pelletier, Kelvin Ng, Wajd Alkabbani, Youssef Labib, Nicolas Mourad

Endocrinol Diabetes Metab· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis